1. What Happened?: Douzone Invests KRW 39.2 Billion in Biotech Innovalley
On August 13, 2025, Douzone BizOn announced a KRW 39.2 billion investment (37.3% stake) in Biotech Innovalley PFV, which is promoting the Chuncheon Enterprise Innovation Park development project. This represents 7.1% of Douzone BizOn’s capital.
2. Why the Investment?: Securing New Growth Engines through AI-based Data Centers
This investment is a strategic move to establish an AI-based data center within the Chuncheon Enterprise Innovation Park. Douzone aims to strengthen its existing software and cloud business competitiveness and secure new growth engines by participating in the creation of a bio/pharmaceutical industry innovation ecosystem.
3. What’s Next?: Investment with Both Opportunities and Concerns
Positive Aspects:
- ▶ Securing future growth engines and business diversification through entry into the AI and data center business
- ▶ Potential for synergy with existing businesses
- ▶ Manageable investment size relative to the company’s scale
Negative Aspects:
- ▶ Uncertainties inherent in real estate development projects (market fluctuations, permitting issues, etc.)
- ▶ Time required for investment returns to materialize
- ▶ Short-term cash outflow
4. What Should Investors Do?: Maintain a Neutral Stance, Seek Additional Information
Experts currently maintain a ‘neutral’ stance. While the investment is a positive move towards securing future growth, the uncertainties of real estate development projects must be considered. Investors should review additional information such as Biotech Innovalley PFV’s business plan, Douzone BizOn’s synergy creation strategy, and macroeconomic variables before making investment decisions.